38 related articles for article (PubMed ID: 26381179)
1. Chemical inhibition of DNA-PKcs impairs the activation and cytotoxicity of CD4
Azevedo-Pouly AC; Appell LE; Burdine L; Rogers LJ; Morehead LC; Fil D; Barker M; Rainwater RR; Waldrip ZJ; Koss B; Burdine MS
Immunol Cell Biol; 2023 Aug; 101(7):663-671. PubMed ID: 37149747
[TBL] [Abstract][Full Text] [Related]
2. DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity.
Sun X; Liu T; Zhao J; Xia H; Xie J; Guo Y; Zhong L; Li M; Yang Q; Peng C; Rouvet I; Belot A; Shu HB; Feng P; Zhang J
Nat Commun; 2020 Dec; 11(1):6182. PubMed ID: 33273464
[TBL] [Abstract][Full Text] [Related]
3. Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts.
Ji J; Dragojevic S; Callaghan CM; Smith EJ; Talele S; Zhang W; Connors MA; Mladek AC; Hu Z; Bakken KK; Sarkaria PP; Carlson BL; Burgenske DM; Decker PA; Rashid MA; Jang MH; Gupta SK; Eckel-Passow JE; Elmquist WF; Sarkaria JN
Mol Cancer Ther; 2024 May; 23(5):662-671. PubMed ID: 38224566
[TBL] [Abstract][Full Text] [Related]
4. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition.
Massey AJ; Stephens P; Rawlinson R; McGurk L; Plummer R; Curtin NJ
Mol Oncol; 2016 Jan; 10(1):101-12. PubMed ID: 26471831
[TBL] [Abstract][Full Text] [Related]
6. PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer.
Fan SJ; Snell C; Turley H; Li JL; McCormick R; Perera SM; Heublein S; Kazi S; Azad A; Wilson C; Harris AL; Goberdhan DC
Oncogene; 2016 Jun; 35(23):3004-15. PubMed ID: 26434594
[TBL] [Abstract][Full Text] [Related]
7. The underlying molecular mechanisms and prognostic factors of RNA binding protein in colorectal cancer: a study based on multiple online databases.
He Q; Li Z; Lei X; Zou Q; Yu H; Ding Y; Xu G; Zhu W
Cancer Cell Int; 2021 Jun; 21(1):325. PubMed ID: 34193169
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of the co-chaperone protein phosphatase 5 in cancer.
Sager RA; Dushukyan N; Woodford M; Mollapour M
Cell Stress Chaperones; 2020 May; 25(3):383-394. PubMed ID: 32239474
[TBL] [Abstract][Full Text] [Related]
9. DNA-PKcs Mediates An Epithelial-Mesenchymal Transition Process Promoting Cutaneous Squamous Cell Carcinoma Invasion And Metastasis By Targeting The TGF-β1/Smad Signaling Pathway.
Zhang J; Jiang H; Xu D; Wu WJ; Chen HD; He L
Onco Targets Ther; 2019; 12():9395-9405. PubMed ID: 31807020
[TBL] [Abstract][Full Text] [Related]
10. Targeting PP2A activates AMPK signaling to inhibit colorectal cancer cells.
Dai C; Zhang X; Xie D; Tang P; Li C; Zuo Y; Jiang B; Xue C
Oncotarget; 2017 Nov; 8(56):95810-95823. PubMed ID: 29221169
[TBL] [Abstract][Full Text] [Related]
11. Identification of DNA-PKcs as a primary resistance factor of TIC10 in hepatocellular carcinoma cells.
Cheng L; Liu YY; Lu PH; Peng Y; Yuan Q; Gu XS; Jin Y; Chen MB; Bai XM
Oncotarget; 2017 Apr; 8(17):28385-28394. PubMed ID: 28415690
[TBL] [Abstract][Full Text] [Related]
12. Liposomal C6 Ceramide Activates Protein Phosphatase 1 to Inhibit Melanoma Cells.
Jiang F; Jin K; Huang S; Bao Q; Shao Z; Hu X; Ye J
PLoS One; 2016; 11(9):e0159849. PubMed ID: 27631768
[TBL] [Abstract][Full Text] [Related]
13. KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms.
Chen MB; Zhou ZT; Yang L; Wei MX; Tang M; Ruan TY; Xu JY; Zhou XZ; Chen G; Lu PH
Oncotarget; 2016 Mar; 7(13):17047-59. PubMed ID: 26933997
[TBL] [Abstract][Full Text] [Related]
14. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer.
Velic D; Couturier AM; Ferreira MT; Rodrigue A; Poirier GG; Fleury F; Masson JY
Biomolecules; 2015 Nov; 5(4):3204-59. PubMed ID: 26610585
[TBL] [Abstract][Full Text] [Related]
15. DNA-PKcs interference sensitizes colorectal cancer cells to a mTOR kinase inhibitor WAY-600.
Wu L; Zhang J; Wu H; Han E
Biochem Biophys Res Commun; 2015 Oct; 466(3):547-53. PubMed ID: 26381179
[TBL] [Abstract][Full Text] [Related]
16. Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.
Zhen YF; Li ST; Zhu YR; Wang XD; Zhou XZ; Zhu LQ
Oncotarget; 2016 Nov; 7(48):79417-79427. PubMed ID: 27765904
[TBL] [Abstract][Full Text] [Related]
17. DNA-dependent protein kinase catalytic subunit (DNA-PKcs)-SIN1 association mediates ultraviolet B (UVB)-induced Akt Ser-473 phosphorylation and skin cell survival.
Tu Y; Ji C; Yang B; Yang Z; Gu H; Lu CC; Wang R; Su ZL; Chen B; Sun WL; Xia JP; Bi ZG; He L
Mol Cancer; 2013 Dec; 12(1):172. PubMed ID: 24365180
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
